CorMedix Inc.·4

Feb 27, 9:46 PM ET

Kaplan Myron 4

4 · CorMedix Inc. · Filed Feb 27, 2020

Insider Transaction Report

Form 4
Period: 2020-02-25
Kaplan Myron
Director
Transactions
  • Award

    Stock Option (Right to Buy Common Stock)

    2020-02-25$5.63/sh+15,000$84,45015,000 total
    Exercise: $5.63Exp: 2030-02-25Common Stock (15,000 underlying)
Holdings
  • Stock Option (Right to Buy Common Stock)

    Exercise: $8.30Exp: 2029-01-10Common Stock (15,000 underlying)
    15,000
  • Stock Option (Right to Buy Common Stock)

    Exercise: $2.85Exp: 2028-02-16Common Stock (8,000 underlying)
    8,000
  • Stock Option (Right to Buy Common Stock)

    Exercise: $21.40Exp: 2026-04-28Common Stock (10,000 underlying)
    10,000
  • Common Stock

    109,734
  • Stock Option (Right to Buy Common Stock)

    Exercise: $11.20Exp: 2027-02-21Common Stock (8,000 underlying)
    8,000
Footnotes (5)
  • [F1]These options were granted on 02/25/2020. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board.
  • [F2]These options were granted on 01/10/2019. These options are fully vested.
  • [F3]These options were granted on 02/16/2018. These options are fully vested.
  • [F4]These options were granted on 02/21/2017. These options are fully vested.
  • [F5]These options were granted on 4/28/2016. These options are fully vested.

Documents

1 file
  • 4
    doc4.xmlPrimary

    PRIMARY DOCUMENT